Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16588
Title: Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand
Austin Authors: Trubiano, Jason A ;Cheng, AC;Korman, TM;Roder, C;Campbell, A ;May, MLA;Blyth, CC;Ferguson, JK;Blackmore, TK;Riley, TV;Athan, E
Affiliation: Austin Health, Heidelberg, Victoria, Australia
Infectious Diseases Department, Austin Health, Heidelberg, Victoria, Australia
Infectious Diseases Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Infectious Diseases Department, Alfred Health, Melbourne, Victoria, Australia
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
Infection Prevention and Healthcare Epidemiology Unit, Alfred Hospital, Melbourne, Victoria, Australia
Monash Infectious Diseases, Monash Health, Monash University, Melbourne, Victoria, Australia
School of Medicine, Deakin University, Geelong, Victoria, Australia
Geelong Centre for Emerging Infectious Diseases, Barwon Health, Geelong, Victoria, Australia
Infectious Diseases Department, Princess Margaret Hospital for Children, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australia
Infection Management and Prevention Service, Lady Cilento Children's Hospital, Brisbane, Queensland, Australia
Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia
School of Paediatrics and Child Health, The University of Western Australia, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australia
Department of Microbiology, PathWest Laboratory Medicine, Princess Margaret Hospital, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australia
Pathology North, NSW Pathology, Wellington South, New Zealand
Immunology and Infectious Diseases Unit, John Hunter Hospital, Wellington South, New Zealand
Universities of New England and Newcastle, Newcastle, New South Wales, Australia
Laboratory Services, Wellington Regional Hospital, Wellington South, New Zealand
Microbiology and Immunology, School of Pathology and Laboratory Medicine, The University of Western Australia, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australia
Department of Microbiology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australia
Department of Infectious Disease, Barwon Health, Geelong, Victoria, Australia
Issue Date: Apr-2016
Publication information: Internal Medicine Journal 2016; 46(4): 479-493
Abstract: The incidence of Clostridium difficile infection (CDI) continues to rise, whilst treatment remains problematic due to recurrent, refractory and potentially severe nature of disease. The treatment of C. difficile is a challenge for community and hospital-based clinicians. With the advent of an expanding therapeutic arsenal against C. difficile since the last published Australasian guidelines, an update on CDI treatment recommendations for Australasian clinicians was required. On behalf of the Australasian Society of Infectious Diseases, we present the updated guidelines for the management of CDI in adults and children.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16588
DOI: 10.1111/imj.13027
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/27062204
Type: Journal Article
Subjects: Clostridium difficile
Faecal microbiota transplant (FMT)
Fidaxomicin
Metronidazole
Treatment
Vancomycin
Appears in Collections:Journal articles

Show full item record

Page view(s)

4
checked on Dec 6, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.